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Abstract
The amyloid precursor protein (APP) is a causal agent in the pathogenesis of Alzheimer’s
disease and is a transmembrane protein that associates with membrane-limited organelles.
APP has been shown to co-purify through immunoprecipitation with a kinesin light chain
suggesting that APP may act as a trailer hitch linking kinesin to its intercellular cargo, how-
ever this hypothesis has been challenged. Previously, we identified an mRNA transcript
that encodes a squid homolog of human APP770. The human and squid isoforms share
60% sequence identity and 76% sequence similarity within the cytoplasmic domain and
share 15 of the final 19 amino acids at the C-terminus establishing this highly conserved
domain as a functionally import segment of the APP molecule. Here, we study the distribu-
tion of squid APP in extruded axoplasm as well as in a well-characterized reconstituted
organelle/microtubule preparation from the squid giant axon in which organelles bind micro-
tubules and move towards the microtubule plus-ends. We find that APP associates with
microtubules by confocal microscopy and co-purifies with KI-washed axoplasmic organelles
by sucrose density gradient fractionation. By electron microscopy, APP clusters at a single
focal point on the surfaces of organelles and localizes to the organelle/microtubule inter-
face. In addition, the association of APP-organelles with microtubules is an ATP dependent
process suggesting that the APP-organelles contain a microtubule-based motor protein.
Although a direct kinesin/APP association remains controversial, the distribution of APP at
the organelle/microtubule interface strongly suggests that APP-organelles have an orienta-
tion and that APP like the Alzheimer’s protein tau has a microtubule-based function.
Introduction
Alzheimer’s disease (AD) is a debilitating neurodegenerative disorder characterized by the loss
of long-term memory, language degeneration, and cognitive impairment. This disease afflicts
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an estimated 26.6 million people worldwide and is predicted to reach an incidence of 100 mil-
lion by 2050 [1]. Pathologically, AD is diagnosed by the presence of amyloid plaques in brain
[2–5] that contain Aβ a peptide fragment of the amyloid precursor protein [6]. While most
forms of AD are considered sporadic, mutations in APP cause heritable forms of this disorder,
thus establishing a causal role for this protein in AD pathogenesis [7–10].
It is well established that APP contains a single transmembrane domain that spans the lipid
bilayer of membrane-limited organelles [11]. APP is cleaved through two distinct enzymatic
pathways, one that yields the pathogenic Aβ fragment and another that cleaves within the Aβ
domain to produce a non-pathogenic physiology [12]. While the N-terminal of APP resides
within the organelle lumen, the C-terminal extends into the neuronal cytoplasm [13]. APP-
associated organelles are transported through processes of fast axonal transport [14] and
immunoprecipitation studies have shown that APP co-purifies with a kinesin light chain [15].
These findings suggest that APP may link kinesin to its cellular cargo, however this theory is
under debate [16].
For many years, we have been interested in motor-driven organelle movements and have
studied these processes in the squid giant axon, the model in which the first direct observations
of axonal transport were made and the system in which conventional kinesin (Kinesin-1) the
founding member of the kinesin motor family was discovered [17–20]. To identify other
motors and to obtain genetic information on squid, we undertook an expressed sequence tag
project by single-pass sequencing randomly selected mRNAs of the squid stellate ganglia.
Along with finding a variety of motors, we identified a single transcript that encodes a squid
homolog of human APP [21]. By immunoblot we find that antibodies to the C-terminal of
human APP recognize a single band in squid axoplasm at the predicted molecular weight of
the squid APP protein, thus demonstrating that APP is present in the squid giant axon [22].
Within the intact squid axon as well as in extruded axoplasm, organelles move bidirection-
ally along microtubules, and in reconstituted motility assays isolated organelles move towards
the microtubule plus-ends [23–26]. Here, we set out to determine the distribution of APP in
this well characterized system. Surprisingly, we find that APP clusters at a single focal point on
the organelle surface and localizes to the organelle/microtubule interface. In addition, these
APP-organelles associate with microtubules in an ATP dependent manner a biochemical char-
acteristic of microtubule-based motors, thus it is likely that APP and a molecular motor coexist
at the juncture between the cargo and the intercellular road.
Materials and Methods
Live North Atlantic Long-Finned Squid Doryteuthis pealeii (formerly Lologo p.) were obtained
from the Marine Resources Department, Marine Biological Laboratory, Woods Hole, Massa-
chusetts. Squid giant axons were dissected under fresh, well-oxygenated, running seawater and
used immediately in the procedures outlined below.
Immuno-fluorescent labeling of APP and tubulin in extruded axoplasm
Axoplasm was extruded from freshly dissected squid axons onto 24X60 mmNo. 1.5 cover glass
and blocked for 1 hour in General Tubulin Buffer (80 mM PIPES (pH 6.9), 1 mM EGTA, 1
mMMgCl2) containing 10 mg/ml BSA and 20 μm paclitaxel (Sigma Aldrich, St Louis MO).
Samples were immuno-labeled for APP and microtubules by incubating axoplasm in a 1:200
dilution each of a rabbit anti-human APP (Invitrogen Inc., Grand Island, NY [product # 51–
2700]) and mouse anti-tubulin antibody (Sigma Aldrich, St Louis, MO [product # T9026]) in
blocking solution for 1 hour. The APP antibody termed CT695 was raised against the final 22
amino acids of the C-terminus of human APP. This epitope is conserved between human and
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mouse homologs (100%) and shares 15 identical (68%) and 19 similar (86%) amino acid resi-
dues with squid APP. Samples were washed in blocking buffer 3 x 10 min and then treated
with 1:200 donkey anti-rabbit Alex Flour1 488 and donkey anti-mouse Alex Flour1 594 fluo-
rescent secondary antibodies diluted in blocking solution (Jackson ImmunoResearch Laborato-
ries, Inc., West Grove, PA). Samples were mounted on glass slides with Vectashield mounting
media (Vector Laboratories, Inc. Burlingame, CA) and imaged with an inverted Zeiss 710
Laser Scanning Confocal Microscope (Carl Zeiss, Microscopy, LLC, Thornwood, NY).
Isolation of KI-washed axoplasmic organelles
KI-washed axoplasmic organelles were obtained as previously described [25,26]. Briefly,
approximately 50 μl of axoplasm was extruded from 10 freshly dissected squid axons into a
50 μl drop of 1/2X buffer (10 mMHEPES–KOH (pH 7.2), 175 mM L-aspartic acid, 65 mM tau-
rine, 85 mM betaine, 25 mM glycine, 6.5 mMMgCl2, 5 mM EGTA, 0.5 mMD-glucose, 1.5
mM CaCl2) containing 1 mMDTT and protease inhibitors (10 mM each of benzamidine, leu-
peptin, pepstatin A, aprotinin, and phenanthroline). Potassium iodide (3 M in 1/2X buffer)
was added to the sample to a final concentration of 600 mM to dissociate the cytoskeleton. The
resulting sample was triturated 30 times with a yellow tipped pipette and then placed on ice for
10 min. The sample was diluted 1:1 in 1/2X buffer and layered onto a three step sucrose gradi-
ent consisting of 100 μl of 45%, 200 μl of 15%, and 100 μl of 12% sucrose in 1/2X buffer layered
within a Beckman 0.7 ml ultracentrifuge tube (Beckman Coulter Inc., Indianapolis, IN). The
sample was centrifuged at 100,000 X g in a Beckman 52Ti swinging bucket rotor at 35,000
RPM for 90 min at 4°C. The supernatant was drawn off the gradient surface by pipette and the
15% sucrose layer containing the KI-washed organelle isolate was removed by side puncture
using a needle and syringe. The supernatant and KI-washed organelles were used for immuno-
blots. Organelles were also used for immunocytochemistry and reconstituted organelle/micro-
tubule preparations.
SDS-PAGE and immunoblot analysis of APP in axoplasmic fractions
Sucrose density gradient samples of axoplasmic supernatants and isolated KI-washed organ-
elles (20 μl each) were run on 10% SDS polyacrylamide gels along with a broad range molecular
weight marker (Bio-Rad Inc. Carlsbad, CA). Parallel gel sets were either Coomassie stained or
transferred to nitrocellulose. Transfers were incubated in a blocking solution for 1 hour (5%
Carnation instant milk, 0.2% Tween-20 in TBS). Blots were incubated in a 1:1,000 dilution of
rabbit anti-human APP antibody in blocking solution for 2 hours followed by 3 X 10 min wash
in blocking solution alone. Blots were incubated in a peroxidase conjugated secondary antibody
(Amersham, GE Healthcare, Waukesha, WI) at 1:5,000 for 1 hour in blocking solution and
then washed 3 X 10 min in Tris Buffered Saline. Blots were soaked in a chemiluminescent
developer and sheet film exposed to the membrane surface. Exposed film was developed and
scanned to obtain a digital image of the immunoblot. Images were color inverted to obtain
black immuno-bands on a white background.
Immunolabeling of isolated KI-washed axoplasmic organelles for TEM
Formvar carbon-coated EM grids were placed on 30 μl drops of isolated KI-washed axoplasmic
organelles for 2 min. EM grids were floated sample side down on 50 μl drops of blocking solu-
tion (10 mg/ml BSA in PBS) for 1 hour. Samples were transferred to drops of anti-APP anti-
body diluted 1:200 in blocking solution for 1 hour, washed 3 x 10 min in blocking solution
alone, and incubated in 12 nm colloidal gold conjugated secondary antibodies in blocking
solution (1:200) for 1 hour (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).
APP Clusters at Organelle/Microtubule Interface
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Samples were washed in PBS 3 X 10 min followed by incubation on drops of 1% uranyl acetate
(UA) in water for 2 min. Excess UA was removed and samples were air dried before imaging.
The samples were imaged with a Jeol CX200 electron microscope (Jeol Ltd., Peabody, MA)
with an AMT camera (Advanced Microscopy Techniques, Corp. Woburn, MA) and gold parti-
cle distribution observed and photographed at 50,000X.
Preparation and immunolabeling of reconstituted organelle/microtubule
complexes in the presence and absence of ATP
Lyophilized bovine tubulin (Cytoskeleton Inc. Denver, CO) was resuspended in General Tubu-
lin Buffer (80 mM PIPES (pH 6.9), 1 mM EGTA, 1 mMMgCl2) containing 5% glycerol and 1
mMGTP to a final tubulin concentration of 0.5 mg/ml and snap frozen in 5 μl aliquots for stor-
age. For experiments, aliquots were thawed and placed at 35°C for 20 min. Warm General
Tubulin Buffer (100 μl) containing 20 μM paclitaxel (Sigma Aldrich, St Louis, MO) was added
to aliquots and tubulin samples incubated at room temperature overnight to promote microtu-
bule polymerization. The resulting microtubule solution was added at a 1:1 ratio by volume to
isolated KI-washed axoplasmic organelles supplemented with 20 μm paclitaxel in the presence
and absence of 10 mMATP final concentration and incubated at room temperature for 30 min.
Formvar carbon-coated EM grids were incubated on 20 μl droplets of organelle/microtubule
samples for 1 min, washed 3 x 5 min in PBS containing 20 μm paclitaxel, and immunolabeled
for APP as outlines above (all solutions contained 20 μm paclitaxel to preserve microtubule
integrity). After immunolabeling, samples were stained in 1% uranyl acetate in water. Samples
with and without ATP were imaged at 50,000 X by transmission electron microscopy. The asso-
ciation of KI-washed APP-organelles with exogenous microtubules in the presence and absence
of ATP were analyzed as outlined below.
Immunolabeling of axoplasmic touch preparations
Axoplasm for squid giant axons was extruded onto parafilm and formvar carbon-coated cop-
per grids touched lightly to the axoplasm to obtain a thin layer of axoplasmic components on
the formvar surface. Samples were immuno-labeled for APP using 12 nm gold secondary anti-
bodies in the presence of 20 μm paclitaxel as outlined above. EM grids were photographed and
APP distribution analyzed.
Results
APP is bound to microtubules in extruded axoplasm by confocal
microscopy
In previous experiments, we found an amyloid precursor protein transcript in squid that
expresses a protein product in the squid giant axon as demonstrated by immunoblot [22]. To
determine whether this APP could be detected in the axon by immunofluorescence, axoplasm
of the squid giant axon was extruded onto glass cover slips, stabilized with taxol, and labeled
with antibodies raised against APP and tubulin (Fig 1). By confocal microscopy, microtubules
appear as thin filaments that intersect one another and stretch out along the glass surface. APP
labeling appears as discrete puncta that often associate with tubulin filaments. Some puncta are
found on the top of the microtubule, while others appear along the microtubule edge. In some
cases, puncta are found in regions distinct from the microtubule domain and may be bound to
the glass surface or to other undetected cytoplasmic elements. The amount of APP labeling
indicates that this protein is abundant in the axon and the intensity of the labeling suggests
that the puncta are composed of multiple APP proteins.
APP Clusters at Organelle/Microtubule Interface
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APP co-purifies with isolated axoplasmic organelles by sucrose density
gradient fractionation
Like human APP, the amino acid sequence of the APP in squid contains a single transmem-
brane domain, suggesting that this protein like human APP spans the membranes of organ-
elles. It has been shown in reconstituted motility assays that organelles isolated from the
squid giant axon move towards the plus-ends of microtubules in an ATP dependent fashion
and that a Kinesin-3 is present on their surfaces [25,26]. In order to determine whether
these organelles also contain APP, organelles were purified in the presence of 600 mM KI
using an established sucrose density gradient protocol developed for investigating microtu-
bule-based transport [25,26]. By immunoblot, we find that APP co-purifies with KI-washed
axoplasmic organelles, while an axoplasmic supernatant is void of detectable levels of APP
protein (Fig 2). APP appears to be abundant in the organelle fraction based on the thickness
and intensity of APP bands obtained in blots. The band detected by anti-APP is in the molec-
ular weight range predicted from the full-length squid APP amino acid sequence of ~70.3
kDa (612 aa [accession no. DQ913735]). The anti-APP antibody recognizes only a single
band in organelle fractions. No other bands are detected suggesting that APP cleavage prod-
ucts or splice variants are not present within the axon. These experiments also demonstrate
that the antibody raised against human APP is a useful tool for studying APP in the squid
system.
Fig 1. Immunofluorescencemicroscopy of APP andmicrotubules in extruded axoplasm. Axoplasm
from the squid giant axon was extruded onto glass coverslips and fluorescently labeled with antibodies to the
amyloid precursor protein (green) and tubulin (red). APP appears as punctate structures attached or
unattached to microtubules lying along the glass surface.
doi:10.1371/journal.pone.0147808.g001
APP Clusters at Organelle/Microtubule Interface
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APP clusters at a single focal point on the surfaces of KI-washed axon
organelles
To determine whether the co-purification of APP with KI-washed organelles in sucrose gradi-
ents is due to a direct association, formvar carbon-coated EM grids were incubated on droplets
of the organelle fraction, labeled for APP, and stained for electron microscopy. As a negative
control, duplicate samples were labeled with the secondary antibody only. By EM, fields of
organelles were found along the formvar surface and many organelles were decorated by APP
antibodies and colloidal gold. Surprisingly, the gold particles appear to cluster on the surfaces
of organelles and appear to localize at single focal point on the organelle surface (Fig 3).
In the electron microscope, fields of APP labeled and control organelles were photographed
at 50,000 X (four experiments, 50 images each) and the number of labeled organelles deter-
mined as a percentage of the total. While 72% of organelles were labeled for APP with a least
Fig 2. SDS-PAGE and immunoblot analysis of sucrose density gradient axoplasmic fractionations.
Total squid axoplasm was treated with 600 mM KI and centrifuged over a three-step sucrose density gradient.
The resulting supernatant and organelle fractions were used for Coomassie stained gels (Coom, S, and O)
and immunoblots (Blot, S, and O) probed with a C-terminal anti-APP polyclonal antibody (see materials and
methods) and detected through chemiluminescence. Dashes indicate molecular weight markers: 250, 150,
100, 75, 50, 37 kDa.
doi:10.1371/journal.pone.0147808.g002
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one gold particle (n = 1,652), only 3% of organelles were label with secondary antibody only
(n = 1,134). APP labeled organelles appear as flattened, round, membranated structures. Since
the APP antibody was raised against the C-terminus of human APP the positive label on organ-
elles demonstrates that the C-terminus of squid APP, like that in human, extends from the
organelle into the neuronal cytoplasm [11].
To investigate APP clustering and distribution of APP relative to the organelle a line was
drawn through the center of each organelle to create two equal hemispheres (set of 50 fields).
The line angle was drawn through the organelle in such a manner to obtain a maximum num-
ber of particles within a single hemisphere, while maintaining a line that contains the center
point of the organelle (fixed point of the circle). Particles were counted within the two hemi-
spheres. Of 273 organelles, 78% contained particles only in a single hemisphere and of organ-
elles that contain particles in both hemispheres (n = 60), 92% of the particles were found in the
particle dominant sector. To determine whether gold particle clustering was due to secondary
antibody clumping, the secondary antibody was diluted 1:1,000 in PBS and formvar-coated
grids incubated on the diluted secondary conjugate. Fields of gold particles were imaged and
singletons and gold clumps counted. Gold clumps were defined as two or more particles closer
than one particle apart (12 nm). Of 1,041 particles only 62 gold clumps (two or more particles
in close proximity) were observed (0.60%).
The finding that APP is clustered on the organelle surface is unpredicted and to the best of
our knowledge is the first direct evidence of full-length APP clustering on membrane surfaces.
In addition, the diameters of labeled organelles were measured along their narrowest axis
and determined to be 97 ± 3 nm (n = 300) the same size as those previously shown to exhibit
attached Kinesin-3 [26].
Fig 3. Immuno-localization of APP to the surfaces of isolated axoplasmic organelles. An APP antibody
raised against the C-terminal of human APP was used to determine whether APP is directly bound to isolated
axoplasmic organelles. Using a colloidal gold secondary antibody, gold particles were found to cluster on the
surfaces of axoplasmic organelles through transmission electron microscopy.
doi:10.1371/journal.pone.0147808.g003
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APP-bound axoplasmic organelles associated with microtubules in an
ATP dependent fashion
The finding that APP clusters and localizes to the surfaces of axoplasmic organelles led us to
wonder whether these same organelles could bind to microtubules in the absence of ATP, a
biochemical characteristic of microtubule-based motor proteins. Both conventional kinesin
and cytoplasmic dynein were purified through microtubule affinity in the absence of ATP
[20,27–31]. These motors move along microtubules with physiological levels of ATP and
release from filaments at High ATP levels. Squid axoplasmic organelles also possess this bio-
chemical characteristic demonstrating that these organelles contain microtubule-based motors
on their surfaces [25].
Here, purified KI-washed organelles were added to taxol stabilized bovine microtubules in
the presence and absence of 10 mM ATP and the mixture incubated at room temperature for
30 minutes (Fig 4). EM grids were incubated of droplets of the samples and immunolabeled for
APP. Samples in the presence and absence of ATP were photographed by transmission electron
microscopy at 50,000X and resulting images analyzed. In samples that lack ATP, organelles
attached to microtubules at a frequency of 1 APP-organelle per 78 microns in microtubule
length, while APP-organelles were found mostly on formvar surfaces unattached to microtu-
bule filaments (1:872 nm) when ATP was present. In addition, APP is found on 67% of the
vesicles found associated with the microtubules. Further analysis of APP-organelle/microtu-
bule complexes showed that 92% of the APP labeled distributed to the organelle/microtubule
interface.
APP localizes to the organelle/microtubule interface in axoplasmic
spreads
To investigate the distribution of APP in axoplasm at the ultrastructural level, EM grids were
touched to the surface of extruded axoplasm to obtain a thin layer of cytoplasmic elements on
the grid surface and the sample immunolabeled for APP. On grids where axoplasm was thin
enough to recognize cellular structures, microtubules, actin, mitochondria, organelles and
other cytoskeletal elements could be seen by negative stain. Gold particles could be seen on
organelle surfaces and labeling appears similar to APP labeling on isolated KI-treated organ-
elles or reconstituted organelle/microtubule complexes. As a negative control additional grids
were labeled with secondary antibody only. Interestingly, the distribution of gold appeared on
organelles at the organelle/microtubule interface (Fig 5) as well as on organelles free from
microtubules on the formvar surface. Not all free or microtubule-bound organelles contain
label.
We determined the density of particle distribution on organelles, along microtubules and in
the background of axoplasmic spreads. Label density was also determined for the background
as well as for control samples in which the axoplasm was labeled with secondary only. The
density of gold particles on microtubules under the organelle is 163 ± 14.6 compared to micro-
tubule domains that lack the presence of an organelle that label at a density of 3.8 ± 0.6 per
100 μm2. Labeling for secondary only was low at organelle/microtubule interfaces, on microtu-
bules alone as well as in the background with the highest labeling of 0.8 ± 0.2 on background
surfaces (Table 1).
To determine whether APP distribution preferentially localized to the organelle/microtu-
bule interface we established an interface zone. We reasoned that a colloidal gold particle
within 25 nm of the interface could be attached to an epitope at that interface given the overall
potential length of the APP cytoplasmic domain as well as the length of the primary antibody
and secondary antibodies and the gold particle. Particles outside of the interface zone, were not
APP Clusters at Organelle/Microtubule Interface
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considered to be attached to an epitope at the interface. In samples labeled for APP, 61% of the
gold particles were within the interface zone, while 39% of the gold particles were found on
the organelle, but were considered to label APP outside of the interface. However, 89% of
labeled organelles that were attached to microtubules contained at least one gold particle at the
interface.
The number of particles on each organelle either attached or unattached to a microtubule
filaments were counted. The percentage of organelles that lacked gold decoration was found
to be 37% and 33% for attached and unattached respectively. For labeled organelles in both
attached and unattached categories, the highest percentage of particle frequency was four.
Some organelles contained more than 10 particles (Fig 6). It should be noted that immunogold
labeling likely underrepresents the number of APP molecules present. Labeling is dependent
on the labeling efficiency in terms of the antibodies ability to bind the antigen. The highly con-
serve antigenic site of APP has been suggested to have multiple binding partners including
Fig 4. APP distribution in reconstituted organelle/microtubule complexes. Isolated KI-organelles were
added to paclitaxel stabilized microtubules at a 1:1 ratio volume:volume and incubated at room temperature
for 30 min to form reconstituted organelle/MT complexes. Formvar carbon coated copper EM grids were
placed on 30 μl drops of complexes to adhere complexes to the grid surface. Complexes were labeled for
APP using an Anti-APP primary antibody and a 12 nm colloidal gold conjugated secondary antibody. Images
were taken at 50,000X with a Jeol 200CX transmission electron microscope and an AMT digital camera.
Representative photos are presented in the montage. Gold particles appear in large foci on each organelle
forming a cluster along the organelle surface, while the adjacent side of the organelle remains free of gold
particles.
doi:10.1371/journal.pone.0147808.g004
APP Clusters at Organelle/Microtubule Interface
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Fig 5. Immuno-gold labeling of axoplasmic touch preparations. Total axoplasm was extruded from a
freshly dissected squid giant axon onto parafilm and formvar carbon-coated copper EM grids touch to the
axoplasm to obtain a thin layer of axoplasmic components on the formvar surface. The sample was labeled
with immuno-gold for the presence of APP using a C-terminal APP antibody.
doi:10.1371/journal.pone.0147808.g005
APP Clusters at Organelle/Microtubule Interface
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kinesin motors and this binding may mask antibody recognition. In addition, the organelles
being labeled are in direct contact with the surface of formvar coated EM grids and hence large
portions of the organelle surface area was blocked from antibody detection.
Discussion
While it is well established that the amyloid precursor protein plays a causal role in Alzheimer’s
disease the endogenous wild-type function of this molecule and the mechanisms through
which it leads to disease is poorly understood. In humans, mice, and other mammals APP is a
member of a small family of proteins including APP and the amyloid precursor-like proteins
APLP1 and APLP2 [11,32–34]. Along with similarities in sequence and domain structure these
proteins appear to be processed in a similar manner as each exhibit alpha, beta, gamma, and
Table 1. Distribution of APP label in axoplasmic spreads (particles/μm2).
Anti-APP Antibody (three experiments) Secondary Only (three experiments)
Organelle/Microtubule Complexes 163 ± 14.6 (n = 562) 0 (n = 502)
Microtubules 3.8 ± 0.6 (100 μm2) 0.4 ± 0.2 (100 μm2)
Background 1.3 ± 0.3 0.8 ± 0.2
doi:10.1371/journal.pone.0147808.t001
Fig 6. Frequency histogram of APP-gold labeling on free organelles and on organelles attached to
microtubules in axoplasmic spreads. The number of gold particles on organelles attached to microtubules
and organelles free frommicrotubules in the cytoplasmwere counted on axoplasmic touch preparations. The
number of gold particles on each organelle was plotted against the percentage of total organelles for both
attached and unattached categories.
doi:10.1371/journal.pone.0147808.g006
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epsilon-like cleavage to yield similar proteolytic fragments [35]. However, of the three only
APP has been implicated in neurological disease.
Knockout experiments aimed at determining function, despite the extensive effort, have
been somewhat disappointing as individual knockouts for all three genes develop only mild
phenotypes. The APP knockout exhibits a 15–20% weight reduction and a slight decrease in
locomotor activity [36], while single knockouts for APLP1 and APLP2 have been largely unin-
formative [37,38]. A highlight of this work has been that APP and APLP1 have been shown to
have overlapping functions with APLP2 as double knockouts of APP/APLP2 and APLP1/
APLP2 exhibit early prenatal death clearly demonstrating an essential function for these pro-
teins [37,38] and the redundancy of APP and APLP2 function indicates that a down regulation
of APP could be a viable treatment for AD as APLP2 could substitute for the vital APP func-
tions without contributing to disease.
In investigations of APP distribution, localization of APP suggests a ubiquitous role as APP
is found in a wide variety of tissue types including brain, spinal cord, retina, spleen, muscle,
kidney, lung, thymus, pancreas, and skin [39, 40]. Within neurons, APP localizes to the cell
body and Golgi, as well as to axons, dendrites, and pre- and postsynaptic terminals [41–45]. It
has been demonstrated that APP is transported to the cell surface in Golgi derived vesicles
where it is incorporated into the cell membrane and is then recycled through clatherin medi-
ated endocytosis [43]. APP has been found to associate with synaptic vesicles in the presynaptic
terminal and in neurons in which APP and APLP2 is depleted there is a decrease in glutamate
release suggesting that APP and APLP2 may be involved in synaptic transmission [46,47].
Many studies suggest that APP acts as a trophic factor involved in regulating cell proliferation,
neuronal development, synaptogenesis, synaptic integrity, synaptic plasticity, and homeostasis
as well as in cell adhesion [48–53].
The primary structure also suggests that APP is multi-functional. The orientation of APP
relative to the vesicle surface is such that the N-terminal of APP resides within the vesicle
lumen, while the single transmembrane domain spans the vesicle membrane and the C-termi-
nal extends into the cellular cytoplasm. The N-terminal domain is characterized by a series of
motifs including a copper-binding domain, a growth-factor-like-domain (GFLD) and an acidic
domain (AcD) each of which likely convey APP activities [11,13,54]. Indeed, APP has been
shown to bind copper and has been attributed to a role in copper homeostasis [55].
Adding to this complexity, intriguingly the C-terminal contains a highly conserved
sequence of unknown function yet this high conservation suggests an important functional
domain that may be responsible for the primary activity of APP and could provide a target for
disease control or prevention. Many studies establish that APP is transported within neurons
[56–59] and some studies suggest that it may play an active role in the transport process. Stud-
ies in which axons are constricted by ligature show a buildup of APP on the proximal side of
the construction demonstrating that APP is in transit in the anterograde direction [60] and
mutations in APP have been shown to disrupt axonal transport in Drosophila [61]. In other
studies, latex beads coated with the conserved sequence and injected into axons move away
from the cell body at rates of fast axonal transport suggesting that this sequence picks up a
motor to propel the beads down the axon [22] and in immunoprecipitation studies APP co-
precipitates with the Kinesin-1 light chain in mouse brain and sciatic nerve indicating a link
between APP and the Kinesin-1 motor [15].
In the current study, we find that APP associates with a well-characterized set of squid axo-
plasmic organelles that move towards the plus ends of microtubules. These organelles bind
microtubules in the absence of ATP and dissociate from filaments in its presence a biochemical
characteristic of microtubule-based motors [20,25]. We find that APP clusters on the organelle
surface at a focal point that localizes to the organelle/microtubule interface where molecular
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motors involved in microtubule-based transport must necessarily lie. These findings are in
agreement with a role for APP in transport processes and indeed that APP may be a potential
link between the motor and its cargo. However, the immunoprecipitation studies mentioned
above have been strongly refuted [16] and evidence presented in the current study along with
results from our previous work [26] argue against a connection between APP and Kinesin-1
at least in the squid system, although it is concurrent with an association between APP and
another kinesin family member.
In the elegant experiments that led to the watershed discovery of conventional kinesin (Kine-
sin-1) and the kinesin motor family, purified squid Kinesin-1 was shown to facilitate microtubule
gliding along glass coverslips and to move latex beads towards the plus-ends of microtubules
[20] and its role attributed to moving organelles along microtubules in vivo. This protein was
shown to be highly abundant in the squid giant axon, however little evidence linked conventional
kinesin to organelles or to organelle trafficking. In our efforts to study microtubule-based trans-
port in the squid system, we found that organelles isolated from squid axoplasm in the presence
of 600 mMKI lacked Kinesin-1 despite the fact that they retained their ability to move towards
microtubule plus-ends. In contrast, we found an abundance of a squid Kinesin-3 that co-purified
with KI-washed organelles through sucrose density gradient fractionation [26]. Antibodies to the
Kinesin-3 protein decorated the surfaces of these organelles and localized to the organelle/micro-
tubule interface in reconstituted systems as well as in extruded axoplasm. In addition, antibodies
to Kinesin-3 inhibited all plus-end microtubule-based movements of isolated organelles in
reconstituted systems suggesting that Kinesin-3 is the only active motor in the KI-washed organ-
elle fraction. Therefore the finding in this study that APP associates with KI-washed organelles
that bind to microtubules in an ATP dependent manner strongly suggests that it is APP and
Kinesin-3 that are found on the same organelle surface.
Our data does not rule out the possibility that Kinesin-1 associates with APP or that Kine-
sin-1 in squid is involved in transport. The high concentration of KI could strip kinesin motors
from APP or the organelle surface. Indeed, the addition of KI to axoplasmic organelles abol-
ishes minus-end directed movements along microtubules in reconstituted motility assays [25].
Minus-end directed movement is reestablished by adding a non-KI treated axoplasmic super-
natant suggesting that dynein or a dynein co-factor is removed or inhibited by KI treatment
[25]. However, the finding that Kinesin-3 remains bound to organelles even in the presence of
high KI concentration demonstrates that this kinesin is tightly linked directly or indirectly to
the organelle surface. In Kinesin-3 experiments organelles contained one or two gold labels a
finding consistent with there being only a single Kinesin-3 on each organelle surface. If Kine-
sin-3 and APP are bound to one another, the purification of Kinesin-3 should yield APP even
under stringent biochemical conditions.
The finding that APP clusters at a single focal point on axoplasmic organelles was surprising
to us as we presumed a random distribution of APP along the organelle surface. In other stud-
ies, myosin V antibodies decorated squid axoplasmic organelles throughout the organelle sur-
face [62]. It has been speculated that APP may be associate with lipid rafts as APP is found in
abundance in insoluble detergent extracts, a hallmark of lipid raft biochemistry [63–67]. The
size of lipid rafts is estimated in the range of 20–40 microns. APP-organelles, in this study,
were approximately 100 nm in diameter and are therefore able to accommodate the putative
raft structure. Rafts may define the boundary of APP clusters and drive the proximity of APP
monomers to one another. Clustering may allow for a coordinated function for APP mono-
mers and rafts may provide a framework for such a coordinated function without requiring
direct monomer/monomer interaction. In other studies oligomerization of amyloid beta-pro-
tein has been detected in human spinal fluid and within primary human neuron suggesting
that aggregation begins intracellularly [68].
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Clustering may also contribute to Aβ aggregation and deposition, however whether APP is
processed in squid has not been determined. By Western blot of extruded squid axoplasm we
failed to detect cleavage products for APP suggesting that this protein is not processed within
axoplasmic organelles prior to vesicle fusion with the cell membrane. However, N-terminal
fragments of APP (NTFs) are of similar molecular weight as full-length APP and therefore
these fragments may not be differentiated in our Western blot experiments. Of ~23,000
expressed sequence tags (ESTs) we previously obtained beta and gamma secretase transcripts
were not detected. However, sequences for subunits such as PEN-2 have been found in other
mollusks including the sea hare Aplysia californica, the freshwater snail Biomphalaria glabrata,
and the Pacific Oyster Crassostrea Gigis. Whether the presence of these transcripts is indicative
of APP processing is debatable. However, the function of wildtype APP may be conserved
cross species. The clustering of APP to a focal point along the microtubules indicated an orien-
tation to the organelle as the APP microdomain defines a functional surface of the organelle
membrane. The fact that the C-terminal of APP is highly conserved demonstrates that the C-
terminal is a functional important part of the molecule. That APP is clustered and found at the
organelle/microtubule interface leads us to propose that the native function of APP, like Tau
has a microtubule-based function and that clustering likely contributes to Aβ deposition.
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